Timolol Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Multicenter Study Assessing the Efficacy and Safety of DE-126 Ophthalmic Solution 0.002% Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
Conditions:   Primary Open Angle Glaucoma;   Ocular Hypertension Interventions:   Drug: DE-126 Ophthalmic Solution 0.002% QD;   Drug: Timolol Maleate Ophthalmic Solution 0.5% BID Sponsor:   Santen Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2021 Category: Research Source Type: clinical trials

Comparative Study of the Efficacy of Either Krytantek Ofteno PF ® or Eliptic Ofteno PF® Plus Gaap Ofteno PF® for POAG or Ocular Hypertension.
Conditions:   Glaucoma, Open-Angle;   Ocular Hypertension Interventions:   Drug: Dorzolamide-timolol-brimonidine and latanoprost;   Drug: Dorzolamide-timolol and latanoprost Sponsor:   Laboratorios Sophia S.A de C.V. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2021 Category: Research Source Type: clinical trials